Trevi Therapeutics (TRVI) Tax Rate (2018 - 2026)

Trevi Therapeutics' Tax Rate history runs 9 years deep, the most recent figure standing at 0.15% for Q1 2026.

• On a quarterly basis, Tax Rate rose 5.0% year-over-year to 0.15% in Q1 2026; TTM through Mar 2026 was 0.17%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.16%, down 1.0% from the prior year.
• Tax Rate retreated to 0.15% in Q1 2026 per TRVI's latest filing, from 0.25% in the prior quarter.
• Across five years, Tax Rate topped out at 0.42% in Q2 2023 and bottomed at 0.23% in Q4 2023.
• The 5-year median for Tax Rate is 0.13% (2025), against an average of 0.15%.
• Across the five-year window, Tax Rate plunged 59 bps in 2023 and soared 55 bps in 2024, its largest moves.
• Year by year, Tax Rate stood at 0.36% in 2022, then plunged by 164 bps to 0.23% in 2023, then jumped by 237 bps to 0.32% in 2024, then declined by 20 bps to 0.25% in 2025, then sank by 40 bps to 0.15% in 2026.
• Per Business Quant, the three latest TRVI Tax Rate figures stand at 0.15% (Q1 2026), 0.25% (Q4 2025), and 0.13% (Q3 2025).